170 related articles for article (PubMed ID: 21912187)
1. Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: a study with paired-pulse transcranial magnetic stimulation.
Schneider MK; Retz W; Gougleris G; Verhoeven WM; Tulen JH; Rösler M
Neuropsychobiology; 2011; 64(4):195-201. PubMed ID: 21912187
[TBL] [Abstract][Full Text] [Related]
2. Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate.
Buchmann J; Gierow W; Weber S; Hoeppner J; Klauer T; Benecke R; Haessler F; Wolters A
Biol Psychiatry; 2007 Nov; 62(9):963-9. PubMed ID: 17719015
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter genotype influences the physiological response to medication in ADHD.
Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
[TBL] [Abstract][Full Text] [Related]
4. Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.
Gilbert DL; Sallee FR; Zhang J; Lipps TD; Wassermann EM
Biol Psychiatry; 2005 Jun; 57(12):1597-600. PubMed ID: 15953499
[TBL] [Abstract][Full Text] [Related]
5. Cortical inhibition in attention deficit hyperactivity disorder: new insights from the electroencephalographic response to transcranial magnetic stimulation.
Bruckmann S; Hauk D; Roessner V; Resch F; Freitag CM; Kammer T; Ziemann U; Rothenberger A; Weisbrod M; Bender S
Brain; 2012 Jul; 135(Pt 7):2215-30. PubMed ID: 22492560
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
[TBL] [Abstract][Full Text] [Related]
7. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD).
Richter MM; Ehlis AC; Jacob CP; Fallgatter AJ
Neurosci Lett; 2007 May; 419(2):137-41. PubMed ID: 17481816
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.
Gilbert DL; Ridel KR; Sallee FR; Zhang J; Lipps TD; Wassermann EM
Neuropsychopharmacology; 2006 Feb; 31(2):442-9. PubMed ID: 16034446
[TBL] [Abstract][Full Text] [Related]
9. Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH).
Buchmann J; Gierow W; Weber S; Hoeppner J; Klauer T; Wittstock M; Benecke R; Haessler F; Wolters A
Neurosci Lett; 2006 Sep; 405(1-2):14-8. PubMed ID: 16815631
[TBL] [Abstract][Full Text] [Related]
10. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
[TBL] [Abstract][Full Text] [Related]
12. Effects of methylphenidate in ADHD adults on target evaluation processing reflected by event-related potentials.
Ohlmeier MD; Prox V; Zhang Y; Zedler M; Ziegenbein M; Emrich HM; Dietrich DE
Neurosci Lett; 2007 Sep; 424(3):149-54. PubMed ID: 17723273
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
14. Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorder.
Tzang RF; Wang YC; Yeh CB; Hsu CD; Liang HY; Yang PC; Liu HJ; Huang YS; Cheng H; Hsu YC; Liu SI; Pan CH; Huang YF; Huang CF; Wu YY; Huang YH; Liu HC; Chang HL
Psychiatry Clin Neurosci; 2012 Feb; 66(1):53-63. PubMed ID: 22250610
[TBL] [Abstract][Full Text] [Related]
15. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
16. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
Ozdag MF; Yorbik O; Ulas UH; Hamamcioglu K; Vural O
Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1267-72. PubMed ID: 15364497
[TBL] [Abstract][Full Text] [Related]
17. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L;
Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560
[TBL] [Abstract][Full Text] [Related]
19. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
[TBL] [Abstract][Full Text] [Related]
20. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
